Featured Research

from universities, journals, and other organizations

Australian Over-50s Walk Away Memory Problems In World-first Trial

Date:
September 5, 2008
Source:
University of Melbourne
Summary:
An Australian study has found that walking for two and a half hours a week can significantly improve memory problems in the over-50s.

An Australian study has found that walking for two and a half hours a week can significantly improve memory problems in the over-50s.

The study was led by Professor Nicola T. Lautenschlager, the Chair of Old Age Psychiatry at the University of Melbourne.

The Fitness for the Ageing Brain Study, conducted over 18 months at the University of Western Australia, is believed to be the first in the world to demonstrate that moderate exercise can positively affect cognitive function.

Professor Lautenschlager said the results were very promising. "We found the improvement in memory occurred not only during the six month trial but also 6 and 12 months after completion of the supervised physical activity program'' she said.

"We have known for a long time that exercise is a great way to improve cardiovascular health, but it may be that in the future exercise can also be recommended to protect against the ageing brain."

The trial divided 170 people who had reported memory problems but did not meet criteria for dementia into two groups.

One group continued their usual activities, the other took part in an 24-week home-based physical activity program with the aim to walk three 50 minute sessions or other moderate exercise each week.

Participants in the exercise group did an average of 142 more minutes in a week, or 20 minutes in a day, than those in the control group.

Professor Lautenschlager said by the end of the study, participants in the exercise group performed better on cognitive tests and had better delayed recall. They also had lower Clinical Dementia Rating Scores.

"We believe this trial is the first to demonstrate that exercise can improve cognitive function in older adults at risk,'' Professor Lautenschlager said.

"Unlike medication, which was found to have no significant effect on mild cognitive impairment, physical activity has the advantage of other health benefits such as preventing depression, quality of life, falls, cardiovascular function and disability."

More than 26 million people worldwide have Alzheimer's Disease have dementia. This is expected to grow to 106.2 million worldwide by 2050.

Professor Lautenschlager said if onset of dementia could be delayed by 12 months, there would be 9.2 million fewer cases worldwide.


Story Source:

The above story is based on materials provided by University of Melbourne. Note: Materials may be edited for content and length.


Journal Reference:

  1. Nicola T. Lautenschlager et al. Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease. Journal of the American Medical Association, 3 September 2008 [link]

Cite This Page:

University of Melbourne. "Australian Over-50s Walk Away Memory Problems In World-first Trial." ScienceDaily. ScienceDaily, 5 September 2008. <www.sciencedaily.com/releases/2008/09/080902171110.htm>.
University of Melbourne. (2008, September 5). Australian Over-50s Walk Away Memory Problems In World-first Trial. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2008/09/080902171110.htm
University of Melbourne. "Australian Over-50s Walk Away Memory Problems In World-first Trial." ScienceDaily. www.sciencedaily.com/releases/2008/09/080902171110.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins